Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT.
Document Type
Journal Article
Publication Date
4-1-2017
Journal
European Journal of Heart Failure : Journal of the Working Group on Heart Failure of the European Society of Cardiology
Volume
19
Issue
4
DOI
10.1002/ejhf.686
Keywords
Clinical Trials Data Monitoring Committees; Clinical Trials as Topic; Heart Failure; Humans; Hyperkalemia; Mineralocorticoid Receptor Antagonists; Patient Safety; Renal Insufficiency; Spironolactone
APA Citation
Bristow, M., Sharma, K., Assmann, S., Linas, S., Gersh, B., Grady, C., Rice, M., Singh, S., Boineau, R., McKinlay, S., & Greenberg, B. (2017). Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT.. European Journal of Heart Failure : Journal of the Working Group on Heart Failure of the European Society of Cardiology, 19 (4). http://dx.doi.org/10.1002/ejhf.686
Peer Reviewed
1
